Project Grant R25AI191201
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $212,169 Project Grant under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) to The Johns Hopkins University to advance mentorship at the Johns Hopkins Integrated Center for Combating Antimicrobial Resistant Bacteria. The project summary indicates the principal investigator has conducted pivotal research on antimicrobial resistant infections, leading to clinical guidelines, and has...
- The National Institute of Allergy and Infectious Diseases (NIAID), through its Allergy and Infectious Diseases Research federal grant program (CFDA 93.855), awarded a $4,874,388 Cooperative Agreement to Duke University on June 13, 2025. The award will fund the "Center for Multiscale Immune Systems Modeling - The Center of Excellence (COE)", a research initiative that brings together experts to develop innovative solutions for multi-scale modeling in infectious and immune-mediated...
- This $402,731 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), authorized under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund a program to increase the number of next-generation physician-scientists who can apply knowledge of microbiology, immunology, and research techniques to improve reproductive, maternal, and child health. The award will support 4 physician-scientists in pediatrics or obstetrics/gynecology residency...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $105,076 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Trustees of Dartmouth College to study the dual function of the T6SS immunity protein TSIT in regulating Pseudomonas aeruginosa biofilm growth. The research aims to test the hypothesis that TSIT acts as a transcription factor, in addition to its role as a T6SS immunity protein, to regulate biofilm formation - a key...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $3,182,827 Project Grant to Duke University to develop a 3D bioprinted alveolar sac model and dual host-microbe spatial transcriptomics technology. The goal is to enhance understanding of how the lung microbiome regulates the host response to influenza virus infection. This Allergy and Infectious Diseases Research (CFDA 93.855) program grant will fund the creation of innovative in vitro technologies to study interactions...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $155,204 Project Grant on May 27, 2025 to the University of Notre Dame DU Lac to conduct research on "Revealing the Structural Determinants of TCR Cross-Recognition via Extended Positional Scanning." The project aims to better understand T cell receptor (TCR) cross-reactivity and improve the safety of TCR-based therapies for conditions like viral infection, cancer, and autoimmunity. The researchers will use...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $162,486 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the Regents of the University of Minnesota to investigate the local and systemic coordination of antiviral immunity by tissue-resident memory CD8 T cells in the skin. The project aims to determine whether CD8 TRM reactivation orchestrates immune cells in the skin and the extent to which skin TRM influence distal immunity....
- The Colorado State University STARR Program in Infectious Disease and Immunology was awarded a $209,164 Project Grant by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855). The award, effective from July 15, 2025 to June 30, 2030, supports the program's overarching goal to recruit, train, and retain outstanding clinician-researchers focused on translational research in infectious disease,...
- This Project Grant award, valued at $127,527.00 and running from November 1, 2025 to April 30, 2028, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855). The funding supports research by Duke University to investigate the role of the RGS12 gene locus in regulating macrophage function, particularly in the context of granuloma formation during mycobacterial infections like...
- The University of California, San Diego (UCSD) was awarded a $3,194,992.00 Project Grant by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant, awarded on July 16, 2025, supports research to study the roles and regulation of tissue-resident CD8 T cells during a persistent viral infection. The research aims to investigate the mechanisms that allow immune cells to adapt and maintain a long-term...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $362,312 Project Grant under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) to Duke University. The 5-year grant, effective September 1, 2025, will establish the TRIDENT (Transdisciplinary Research in Infectious Diseases to Engage Third-Year Medical Students) program. TRIDENT aims to recruit and match third-year MD students with multidisciplinary infectious disease researchers at Duke to conduct mentored research projects in focus areas such as infection control, antimicrobial resistance, HIV, global health, and immunology. The program will also provide interdisciplinary faculty and peer mentorship as well as tailored skills and career development curricula for the student trainees. The goal is to build a pipeline of future leaders in infectious disease research by exposing medical students early in their training to the breadth of research opportunities in this field.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $362.3k | 9/11/25 |